Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002366767 | SCV002664543 | uncertain significance | Cardiovascular phenotype | 2020-11-17 | criteria provided, single submitter | clinical testing | The c.1227G>C variant (also known as p.L409L), located in coding exon 2 of the KCNJ5 gene, results from a G to C substitution at nucleotide position 1227. This nucleotide substitution does not change the leucine at codon 409. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration may result in the creation or strengthening of a novel splice donor site. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003098316 | SCV003275360 | likely benign | Long QT syndrome | 2023-01-23 | criteria provided, single submitter | clinical testing |